AMORPHOUS FORM OF APREMILAST
    3.
    发明公开

    公开(公告)号:EP3143004A4

    公开(公告)日:2017-11-08

    申请号:EP14892030

    申请日:2014-07-20

    申请人: MAPI PHARMA LTD

    IPC分类号: C07D209/44 A61K31/4035

    摘要: The present invention provides a new amorphous form of apremilast, pharmaceutical compositions comprising same, methods for preparation and use thereof in treating conditions mediated by inhibition of TNF-α production or inhibition of phosphodiesterase 4 (PDE4), e.g., psoriatic arthritis and other chronic inflammatory diseases.